140 related articles for article (PubMed ID: 36441260)
1. Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma.
Zhang L; Chen S; Huang M; Wang W; Liang Y; Wang Y
Ann Hematol; 2023 Jan; 102(1):125-132. PubMed ID: 36441260
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of semi-quantitative parameters of
Wan B; Zhang S; Wang P; Deng P; Dai W
Ann Nucl Med; 2023 Mar; 37(3):155-165. PubMed ID: 36528697
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory and Nutritional Scoring System for Predicting Prognosis in Patients with Newly Diagnosed Multiple Myeloma.
Zhang L; Chen S; Wang W; Wang Y; Liang Y
J Inflamm Res; 2023; 16():7-17. PubMed ID: 36636247
[TBL] [Abstract][Full Text] [Related]
4. [Predictive Value of Pre-treatment Serum Uric Acid Level for Prognosis in Newly Diagnosed Patients with Multiple Myeloma].
Xu SQ; Zhao P; Wang ZH; Deng H; Zhang L; Wei J; Zou XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1216-1223. PubMed ID: 34362505
[TBL] [Abstract][Full Text] [Related]
5. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.
D'Agostino M; Cairns DA; Lahuerta JJ; Wester R; Bertsch U; Waage A; Zamagni E; Mateos MV; Dall'Olio D; van de Donk NWCJ; Jackson G; Rocchi S; Salwender H; Bladé Creixenti J; van der Holt B; Castellani G; Bonello F; Capra A; Mai EK; Dürig J; Gay F; Zweegman S; Cavo M; Kaiser MF; Goldschmidt H; Hernández Rivas JM; Larocca A; Cook G; San-Miguel JF; Boccadoro M; Sonneveld P
J Clin Oncol; 2022 Oct; 40(29):3406-3418. PubMed ID: 35605179
[TBL] [Abstract][Full Text] [Related]
6. 1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China.
Li X; Chen W; Wu Y; Li J; Chen L; Fang B; Feng Y; Liu J; Chen M; Gu J; Huang B; Li J
Oncologist; 2019 Nov; 24(11):e1132-e1140. PubMed ID: 31455749
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of the controlling nutritional status score in patients with multiple myeloma.
Kamiya T; Ito C; Fujita Y; Ogura S; Mizuno K; Sakurai A; Aisa Y; Nakazato T
Leuk Lymphoma; 2020 Aug; 61(8):1894-1900. PubMed ID: 32306801
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and outcomes of patients newly diagnosed with multiple myeloma with extramedullary disease].
Wang J; Zhang LN; Shi QL; Qu XY; Chen LJ; Li JY; Zhang R
Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):822-828. PubMed ID: 33190439
[No Abstract] [Full Text] [Related]
9. Vitamin D deficiency linked to abnormal bone and lipid metabolism predicts high-risk multiple myeloma with poorer prognosis.
Bao L; Wang YT; Lu MQ; Chu B; Shi L; Gao S; Fang LJ; Xiang QQ; Ding YH; Liu X; Zhao X; Wang MZ; Chen Y; Hu WK
Front Endocrinol (Lausanne); 2023; 14():1157969. PubMed ID: 37181039
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomogram incorporating cytokines for overall survival in patients with newly diagnosed multiple myeloma.
Cheng Q; Zhao F; Zhang B; Zhang Y; Cai L; Qiao B; Hu Y; Sun C
Int Immunopharmacol; 2021 Oct; 99():108016. PubMed ID: 34385029
[TBL] [Abstract][Full Text] [Related]
11. Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study.
Fan H; Wang W; Zhang Y; Wang J; Cheng T; Qiu L; Wang X; Xia Z; An G
Cancer Biol Med; 2023 Jan; 20(1):77-87. PubMed ID: 36647781
[TBL] [Abstract][Full Text] [Related]
12. [A Propensity Score Matching Study of Autologous Hematopoietic Stem Cell Transplantation and New Drug Chemotherapy for Newly Diagnosed Multiple Myeloma].
Yang FY; Wang HF; Xia LH; Wang QQ; Qian CJ; He J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):158-165. PubMed ID: 35123620
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
Mao X; Yan W; Mery D; Liu J; Fan H; Xu J; Xu Y; Sui W; Deng S; Zou D; Du C; Yi S; van Rhee F; Barlogie B; Shaughnessy JD; Anderson KC; Zhan F; Qiu L; An G
Am J Hematol; 2024 Apr; 99(4):523-533. PubMed ID: 38247315
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of clinical and prognostic characteristics of newly diagnosed multiple myeloma with myelofibrosis patients].
Zhang L; Li YL; Liu YM; Liu YB; Shang BJ; Cheng W; Dong XY; Zhu ZM
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):57-62. PubMed ID: 38178769
[No Abstract] [Full Text] [Related]
15. Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective study.
Cohen YC; Saranga A; Gatt ME; Lavi N; Ganzel C; Magen H; Avivi I; Tadmor T; Suriu C; Jarchowsky Dolberg O; Papushado A; Trestman S; Ram R
Am J Hematol; 2018 Jun; 93(6):810-815. PubMed ID: 29603773
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Mayo Additive Staging System in patients with newly diagnosed multiple myeloma: A real-world analysis.
Chen H; Shi H; Zhou N; Yu W; Wu L; Peng R; Wei W; Wang D; Zhou F
Eur J Haematol; 2023 Mar; 110(3):229-235. PubMed ID: 36366975
[TBL] [Abstract][Full Text] [Related]
17. A Prognostic Model Based on Nutritional Risk Index in Operative Breast Cancer.
Lin F; Xia W; Chen M; Jiang T; Guo J; Ouyang Y; Sun H; Chen X; Deng W; Guo L; Lin H
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145159
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the Prognostic Value and Risk Factors of Early Relapse for Newly Diagnosed Multiple Myeloma Patients in the Era of Novel Agents].
Li QH; Liu Y; Wang J; Wang JJ; Dong F; Yang P; Wan W; Ke XY; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):148-153. PubMed ID: 36765492
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Utility of Nutritional Risk Index in Patients with Head and Neck Soft Tissue Sarcoma.
Jiao Z; Liang C; Luo G; Liu M; Jiang K; Yang A; Liang Y
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771348
[TBL] [Abstract][Full Text] [Related]
20. Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation.
Geng C; Zhou H; Wang H; Li Y; Leng Y; Zhang Z; Jian Y; Yang G; Chen W
BMC Cancer; 2022 Dec; 22(1):1349. PubMed ID: 36564753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
